Definition of Synovial Mesenchymal Stem Cells for Meniscus Regeneration by the Mechanism of Action and General Amp1200 Gene Expression
Nakamura K., Kitahashi T., Kogawa R., Yoshino Y., Ogura I.
Animal Study on Meniscus Injury, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Int J Mol Sci (2024)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 39408838
- PMCID
- PMC11476826
- DOI
- 10.3390/ijms251910510
- Citations
- 3
Abstract (original English)
The quality control (QC) of pharmaceutical-grade cell-therapy products, such as mesenchymal stem cells (MSCs), is challenging. Attempts to develop such products have been hampered by difficulties defining cell-type-specific characteristics and therapeutic mechanisms of action (MoAs). Although we have developed a cell therapy product, FF-31501, consisting of human synovial MSCs (SyMSCs), it was difficult to find specific markers for SyMSCs and to define the cells separately from other MSCs. The purpose of this study was to create a method for identifying and defining SyMSCs from other tissue-derived MSCs and to delve deeper into the mechanism of action of SyMSC-induced meniscus regeneration. Specifically, as a cell-type-dependent approach, we constructed a set of 1143 genes (Amp1200) reported to be associated with MSCs and established a method to evaluate them by correlating gene expression patterns. As a result, it was possible to define SyMSCs separately from other tissue-derived MSCs and non-MSCs. In addition, the gene expression analysis also highlighted TNSF-15. The in vivo rat model of meniscus injury found TNSF-15 to be an essential molecule for meniscus regeneration via SyMSC administration. This molecule and previously reported MoA molecules allowed an MoA-dependent approach to define the mechanism of action for SyMSCs. Therefore, SyMSCs for meniscus regeneration were d
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Optimizing Meniscus Allograft Transplantation - Reducing Extrusion and Restoring Joint Loading Mechanics: A Systematic Review
Systematic Review on Osteoarthritis, Meniscus Injury, published in Curr Rev Musculoskelet Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Rev Musculoskelet Med - Level ASystematic ReviewEurope PMC
Emerging biologic augmentation strategies for meniscal repair: a systematic review
Systematic Review with a reported sample of 18 on Meniscus Injury, Chronic Wound, published in BMC Musculoskelet Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 18
BMC Musculoskelet Disord7 citations - Level ASystematic ReviewEurope PMC
Osteoarthritis After Anterior Cruciate Ligament Reconstruction: A Systematic Review of Contributing Factors and Potential Treatments
Systematic Review on Osteoarthritis, Meniscus Injury, Ligament Injury, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level ASystematic ReviewPubMed
Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.
Systematic Review on Osteoarthritis, Meniscus Injury, published in Knee Surg Sports Traumatol Arthrosc (2022) — summary generated from the PubMed abstract.
- 2022
Knee Surg Sports Traumatol Arthrosc40 citations - Level ASystematic ReviewPubMed
Cell-based therapy in soft tissue sports injuries of the knee: a systematic review.
Systematic Review with a reported sample of 9 on Osteoarthritis, Meniscus Injury, Tendon Injury, Ligament Injury, published in Expert Opin Biol Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 9
Expert Opin Biol Ther10 citations - Level ASystematic ReviewPubMed
Stem cells application in meniscal tears: a systematic review of pre-clinical and clinical evidence.
Systematic Review on Meniscus Injury, published in Eur Rev Med Pharmacol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Eur Rev Med Pharmacol Sci